Navigation Links
Cell Biosciences Announces US Patent Issuance
Date:12/14/2010

SANTA CLARA, Calif., Dec. 14, 2010 /PRNewswire/ -- Cell Biosciences, Inc. today announced the issuance of Patent No. 7,846,676 for "Methods and Devices for Analyte Detection" by the United States Patent and Trademark Office.

The patent represents a key element of intellectual property related to NanoPro assay technology. It is one of several within a family directed towards the detection of specific proteins in complex biological samples. NanoPro assay technology is used by premier researchers in the fields of cancer research, stem cell biology, diabetes and drug development to characterize proteins in extremely small and precious samples, enabling accelerated development of new therapeutics and identification of new prognostic and diagnostic disease biomarkers.

"The NanoPro platform represents a transformational approach to protein characterization," commented Bob Gavin, Vice President of Product Development at Cell Biosciences. "The platform's ability to study proteins in extremely small samples has led to its adoption by leading research institutions and drug development companies worldwide. We look forward to continuing the delivery of innovative products based on this technology."

About Cell Biosciences

Our company develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine. With an installed base of over 10,000 systems, our customers include leading research institutions and pharmaceutical/biotechnology companies worldwide. Cell Biosciences is headquartered in Santa Clara, California, with direct sales and service in North America, Europe and Asia.  For more information, visit www.cellbiosciences.com.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015   Decision Resources Group finds ... Europe will continue to be hindered in ... Eurozone. On a longer timeline, however, the outlook is ... active will increase the prevalence of osteoarthritic damage and ... orthopedic soft tissue solutions. Coupled with continuing economic recovery ...
(Date:7/29/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider ... the Life Sciences sector, by setting up Intelent ... 3 million USD . Intelent aims to address the ... projections by McKinsey) by providing clients offerings in the areas ... Noting the exponential growth in ...
(Date:7/29/2015)... , July 29, 2015 Touro College has announced ... CanniCare,s application for one of five media marijuana licenses to ... Dept. of Health (DOH).  If CanniCare ... medicinal cannabis.  "Our college is supportive of ... president of the Touro College System. "There is still a ...
Breaking Medicine Technology:The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 2TAKE Solutions Creates a New Subsidiary for Life Sciences Big Data in the US 3Touro College Announces Support for CanniCare's Medical Cannabis License Application 2
... MYL ) today announced that it intends to ... facility is expected to be comprised of a $1 billion ...  The facility will have a five year term and include ... in November 2011, subject to market and other customary conditions. ...
... HAYWARD, Calif., Oct. 12, 2011 Ultra Clean Holdings, Inc. ... of critical subsystems for the semiconductor capital equipment, flat panel, ... its third quarter  2011 on Monday, October 24, 2011 after ... call to discuss third quarter 2011 results and management,s outlook ...
Cached Medicine Technology:
(Date:7/29/2015)... ... ... A June 10, 2015 article from the News-Press, entitled " It's Never ... regular skin cancer screenings from an early age. Skin cancer can strike at any ... skin cancer is rarely fatal; however, if left alone for too long, the fatality ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... two patients in a Clinical Performance Study for the Invisiport at Wheaton Franciscan ... 6 French catheter options, offers a less invasive, patient-friendly alternative to traditional chest ...
(Date:7/29/2015)... ... July 29, 2015 , ... Attorneys representing American families in national talcum powder ... website now features a page dedicated to news related to pending talcum powder lawsuits, ... Talcum Powder Lawsuit News page was launched with eight initial articles. , “We ...
(Date:7/29/2015)... ... 29, 2015 , ... The New Foundation AZ recently started a ... will cost the 501(c) organization nearly $1 million, will both update the facilities’ design ... took it down to the studs,” said Geraldine Leary, the New Foundation AZ chief ...
(Date:7/29/2015)... ... 29, 2015 , ... National non-profit World T.E.A.M. Sports announced ... employee benefits and asset management, has joined as presenting sponsor for the inaugural ... Charlotte, North Carolina on October 2-4, 2015. , Hosted at the U.S. ...
Breaking Medicine News(10 mins):Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3
... Physicians now have access to real time radiology ... Viewbox (patent pending) is a portable interface system ... specialist consultation to physicians using any internet-ready device. ... in transmitting patient information and offers a timely ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... can increase the risk of surgical site infections in ... long been aware that people with diabetes are more ... blood sugar and increased risk of infection after surgery ...
... imaging (MRI) may be sufficient for the routine surveillance of ... cavae]) stents that are commonly used to treat congenital heart ... great vessels that is present at birth) in children and ... of the American Journal of Roentgenology ( www.ajronline.org ...
... (JHS) will be observed on Sept. 23-24 in Jackson, ... to investigate genetic factors that affect high blood pressure, ... diseases in African-Americans. "Cardiovascular disease is ... United States. The Jackson Heart Study is exploring ...
... Reporter , MONDAY, Sept. 20 (HealthDay News) -- Annual flu shots ... a shot is given the greater the protection, a new British ... reduced by 19 percent for those who had a vaccination in ... and prehospital health care at the University of Lincoln. The ...
... in ten U.S. adolescents uses sunless tanning products, and ... regular tanning may reduce sunbathing and sunburns among adult ... of Archives of Dermatology , one of the ... to the highest cancer risk category and is the ...
Cached Medicine News:Health News:Virtual Viewbox offers portable radiology access for physicians 2Health News:High Blood Sugar Levels Increase Infection Risk From General Surgery 2Health News:High Blood Sugar Levels Increase Infection Risk From General Surgery 3Health News:MRI could be used for routine surveillance of great vessel stents 2Health News:NIH celebrates 10 years of research into health disparities 2Health News:Study Claims Flu Shots Associated With Lower Risk of Heart Attack 2Health News:Study Claims Flu Shots Associated With Lower Risk of Heart Attack 3Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 2Health News:Use of sunless tanning products common in teens, may encourage sun safety in women 3
PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD....
Custom Conjugation Services...
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: